RESUMO
Suckling "F/A2" mice, which overexpress arginase-I in their enterocytes, develop a syndrome (hypoargininemia, reduced hair and muscle growth, impaired B-cell maturation) that resembles IGF1 deficiency. The syndrome may result from an impaired function of the GH-IGF1 axis, activation of the stress-kinase GCN2, and/or blocking of the mTORC1-signaling pathway. Arginine deficiency inhibited GH secretion and decreased liver Igf1 mRNA and plasma IGF1 concentration, but did not change muscle IGF1 concentration. GH supplementation induced Igf1 mRNA synthesis, but did not restore growth, ruling out direct involvement of the GH-IGF1 axis. In C2C12 muscle cells, arginine withdrawal activated GCN2 signaling, without impacting mTORC1 signaling. In F/A2 mice, the reduction of plasma and tissue arginine concentrations to â¼25% of wild-type values activated GCN2 signaling, but mTORC1-mediated signaling remained unaffected. Gcn2-deficient F/A2 mice suffered from hypoglycemia and died shortly after birth. Because common targets of all stress kinases (eIF2α phosphorylation, Chop mRNA expression) were not increased in these mice, the effects of arginine deficiency were solely mediated by GCN2.
Assuntos
Erros Inatos do Metabolismo dos Aminoácidos/enzimologia , Arginase/biossíntese , Arginina/deficiência , Proteínas Serina-Treonina Quinases/metabolismo , Transdução de Sinais , Erros Inatos do Metabolismo dos Aminoácidos/genética , Animais , Animais Lactentes/metabolismo , Arginase/genética , Arginina/genética , Linfócitos B/enzimologia , Hormônio do Crescimento/genética , Hormônio do Crescimento/metabolismo , Doenças do Cabelo/enzimologia , Doenças do Cabelo/genética , Hipoglicemia/enzimologia , Hipoglicemia/genética , Fator de Crescimento Insulin-Like I/genética , Fator de Crescimento Insulin-Like I/metabolismo , Alvo Mecanístico do Complexo 1 de Rapamicina , Camundongos , Camundongos Knockout , Complexos Multiproteicos , Doenças Musculares/enzimologia , Doenças Musculares/genética , Proteínas Serina-Treonina Quinases/genética , Proteínas , Síndrome , Serina-Treonina Quinases TORRESUMO
BACKGROUND: Pili annulati is an inherited hair shaft abnormality with a wide range of clinical expression. OBJECTIVE: We have examined closely three kindreds to reveal levels and character of expression of the phenotype and supplement current literature on the threshold for detection and aspects of hair shaft fragility. PATIENTS AND METHODS: Eleven cases of pili annulati from three families were included in a clinical and morphological study. All cases were assessed clinically and by light and scanning electron microscopy (SEM) of hair shafts. In addition, transmission electron microscopy (TEM) (four patients) and amino acid analysis (three patients) were undertaken on clinically overt cases. Results Examination by light microscopy with a fluid mountant was more sensitive than clinical examination, increasing the detection rate by 120%. Microscopic examination revealed that the characteristic periodic bands become less frequent distally in the hair shaft. Microscopic features of weathering were found in two cases, adding pili annulati to the list of structural hair shaft dystrophies that may weaken hair and dispose to weathering. Amino acid analysis of the hair of three patients with pili annulati showed elevated lysine and decreased cystine content compared to 12 normal controls, consistent with the reduced threshold for weathering. CONCLUSION: Careful light microscopy with fluid-mounted hair is needed to detect subjects mildly affected by pili annulati. Expression of the phenotype varies widely between individuals, between hairs and within hairs of the same individual, where ageing of the hair diminishes detectable features.
Assuntos
Doenças do Cabelo/diagnóstico , Doenças do Cabelo/genética , Aminoácidos/análise , Feminino , Cabelo/anormalidades , Cabelo/ultraestrutura , Doenças do Cabelo/patologia , Humanos , Masculino , Microscopia , Microscopia Eletrônica de Varredura , Linhagem , FenótipoRESUMO
Sparse-fur (spf) mutant mice with X-linked ornithine transcarbamylase deficiency were used to study the effect of L-carnitine on energy metabolites in congenital hyperammonemia. L-Carnitine was used at doses of 2, 4, 8, or 16 mmol/kg body weight (BW), and levels of ammonia, glutamine, glutamate, and some intermediates of energy metabolism were measured in brain and liver of spf/Y mice. Cerebral and hepatic levels of ammonia were decreased with 4 mmol L-carnitine (P < .001), whereas other doses did not seem to have any effect on this metabolite. Cerebral levels of glutamine were decreased following administration of L-carnitine at doses of up to 4 mmol/kg BW, whereas hepatic glutamine levels remained unaltered at all doses of L-carnitine. Both cerebral and hepatic levels of pyruvate, lactate, and alpha-ketoglutarate were decreased at doses of up to 8 mmol L-carnitine/kg BW. L-Carnitine treatment elevated adenosine triphosphate (ATP), free coenzyme A (CoA), and acetyl CoA levels in both brain and liver of spf/Y mice. Cytosolic and mitochondrial redox ratios of spf/Y mice, which were altered by congenital chronic hyperammonemia, were partially corrected by L-carnitine administration. L-Carnitine supplementation to spf/Y mice during sodium benzoate therapy also restored the availability of free CoA and ATP, thus counteracting the adverse effects of higher doses of sodium benzoate. These changes in free CoA and acetyl CoA levels could be due to the deinhibition of pantothenate kinase and stimulation of fatty acid oxidation by L-carnitine.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Amônia/sangue , Benzoatos/uso terapêutico , Encéfalo/metabolismo , Carnitina/farmacologia , Metabolismo Energético/fisiologia , Glutamatos/metabolismo , Glutamina/metabolismo , Doenças do Cabelo/genética , Fígado/metabolismo , Trifosfato de Adenosina/análise , Trifosfato de Adenosina/metabolismo , Erros Inatos do Metabolismo dos Aminoácidos/sangue , Erros Inatos do Metabolismo dos Aminoácidos/metabolismo , Erros Inatos do Metabolismo dos Aminoácidos/fisiopatologia , Amônia/análise , Amônia/metabolismo , Animais , Ácido Benzoico , Peso Corporal/fisiologia , Encéfalo/enzimologia , Química Encefálica , Carnitina/fisiologia , Coenzima A/análise , Coenzima A/metabolismo , Relação Dose-Resposta a Droga , Ligação Genética , Glutamatos/análise , Ácido Glutâmico , Glutamina/análise , Ácidos Cetoglutáricos/análise , Ácidos Cetoglutáricos/metabolismo , Lactatos/análise , Lactatos/metabolismo , Fígado/química , Fígado/enzimologia , Masculino , Camundongos , Camundongos Mutantes , Ornitina Carbamoiltransferase/análise , Ornitina Carbamoiltransferase/fisiologia , Piruvatos/análise , Piruvatos/metabolismo , Fatores de Tempo , Ureia/metabolismoRESUMO
The Netherton-syndrome is a rare disease which is probably inherited through an autosomal recessive trait. It is defined by a triad of symptoms: congenital ichthyosiform erythrodermia , trichorrhexis invaginata et nodosa ("bamboo hair") and atopy. Additional disorders affect the immune system, the metabolism of amino acids and the physical development. On the basis of a new case, the cellular immune defect and the genetic background of the disease are more clearly defined. A new form of treatment--a combination of photochemotherapy (PUVA) and systematic application of aromatic retinoid--has so far proved to be successful. In order to establish an accurate diagnosis--a prerequisite for this promising therapeutic approach--diseases with similar symptoms are discussed for comparison.